Voyager Therapeutics VYGR
NASDAQ VYGR
$2.68 +0.04 (+1.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Operating Interest Expenses (2014)

Updated

Voyager Therapeutics' Operating Interest Expenses was $9.75 million in FY2015, up 400.3% from $1.95 million in FY2014.

Analysis

Voyager Therapeutics (VYGR) Operating Interest Expenses (2014) Analysis & Trends

  • Per Business Quant data, Operating Interest Expenses in earlier years was $1.95 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Voyager Therapeutics 161.76 Mn -501.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 195,000.00
Sep 30, 2014 349,000.00
API Access

Voyager Therapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=VYGR&period=max&api_key=YOUR_API_KEY